We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Euroscreen Announces the Completion of Research Agreement with GNF and Novartis
News

Euroscreen Announces the Completion of Research Agreement with GNF and Novartis

Euroscreen Announces the Completion of Research Agreement with GNF and Novartis
News

Euroscreen Announces the Completion of Research Agreement with GNF and Novartis

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Euroscreen Announces the Completion of Research Agreement with GNF and Novartis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Euroscreen and GNF will be engaged in research focused upon the development of therapeutic antibodies targeting G protein coupled receptors (GPCRs).

Commenting on the new research collaboration, Dr. Jean Combalbert, Euroscreen's CEO indicated, "Euroscreen has years of success in soliciting anti-GPCR antibodies, and more specifically, anti-GPCR antibodies with agonist or antagonist activities. This new deal is again demonstrating our great interest to anti-GPCR antibodies collaborations to develop therapeutic antibodies against relevant targets."
 
Combalbert continues, "Therapeutic antibodies are well recognized to provide excellent efficacy and rapid development time frames. This agreement with GNF and Novartis is a logical extension of our own strategy to develop new therapeutics for unmet medical needs. Both partners are combining their expertise and making commitments of resources to the collaboration."

Advertisement